Clinical Trial Update: Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating letrozole in combination with RAD001 (everolimus) for advanced or recurrent endometrial cancer; the study status is ACTIVE_NOT_RECRUI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Afinitor (everolimus)
• FEMARA (letrozole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-12-13